≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Systemic atrophies primarily affecting the central nervous system

DOID EFO Endpoint Browser PheWeb

G6_NEUATR

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — G10-G13
  • Cause of death: ICD-10 — G10-G13

2 out of 7 registries used, show all original rules.

1301

4. Check minimum number of events

None

1301

5. Include endpoints

1490

6. Filter based on genotype QC (FinnGen only)

1490

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 16815 7755 8724
Only index persons 10265 4914 5351
Unadjusted period prevalence (%)
Whole population 0.24 0.22 0.24
Only index persons 0.19 0.18 0.20
Median age at first event (years)
Whole population 61.80 62.97 60.68
Only index persons 60.13 60.86 59.47

-FinnGen-

Key figures

All Female Male
Number of individuals 1490 635 855
Unadjusted period prevalence (%) 0.31 0.22 0.38
Median age at first event (years) 61.71 59.64 63.25

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1346
Matched controls
13461
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G12.2
ICD-10 Finland
Motor neuron disease
9642.9
323.0
580
*
G11.9
ICD-10 Finland
Hereditary ataxia, unspecified
+∞
216.6
202
*
N07XX02
ATC
riluzole; oral
+∞
166.1
156
*
N99
ICPC
Neurological disease other
56.2
159.5
189
39
G12.9
ICD-10 Finland
Spinal muscular atrophy, unspecified
+∞
133.6
126
*
R47.1
ICD-10 Finland
Dysarthria and anarthria
46.0
117.1
144
35
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
24.4
111.0
160
74
G11.2
ICD-10 Finland
Late-onset cerebellar ataxia
+∞
104.5
99
*
J96.1
ICD-10 Finland
Chronic respiratory failure
13.8
94.7
169
139
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.1
93.4
283
565
JDB10
NOMESCO Finland
Percutaneous gastrostomy
21.3
93.2
140
73
G12.8
ICD-10 Finland
Other spinal muscular atrophies and related syndromes
+∞
90.6
86
*
N28
ICPC
Limited function/disability (N)
19.4
82.0
127
72
R27.0
ICD-10 Finland
Ataxia, unspecified
70.5
75.4
86
13
1380A
ICD-9 Finland
Late effects of acute poliomyelitis[SEQUELAE POLIOMYELITIDIS]
+∞
70.4
67
*
R13
ICD-10 Finland
Dysphagia
5.6
67.1
211
429
TAB00
NOMESCO Finland
Lumbar puncture
7.9
66.7
160
225
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.5
61.4
169
289
G12.1
ICD-10 Finland
Other inherited spinal muscular atrophy
+∞
60.9
58
*
G11.8
ICD-10 Finland
Other hereditary ataxias
+∞
60.9
58
*
M03BX01
ATC
baclofen; systemic
20.2
58.7
89
47
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
7.4
57.8
145
217
Z51.5
ICD-10 Finland
Palliative care
5.0
57.0
197
442
N03AE01
ATC
clonazepam; systemic
5.5
56.8
179
362
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.6
54.9
209
519
Z31.5
ICD-10 Finland
Genetic counselling
7.2
53.3
135
204
L28
ICPC
Limited function/disability (L)
3.1
52.8
342
1320
R4130
NOMESCO Finland
Speech therapy
10.0
52.5
108
116
SPAT1229
SPAT
Assessment of need for aid
4.1
48.7
209
578
N29
ICPC
Neurological sympt/complt other
10.8
45.7
90
89
R1250
NOMESCO Finland
Evaluation of functional capability
10.6
43.9
87
87
G11.4
ICD-10 Finland
Hereditary spastic paraplegia
+∞
41.9
40
*
B91
ICD-10 Finland
Sequelae of poliomyelitis
62.1
41.5
48
8
A28
ICPC
Limited function/disability NOS
2.8
40.8
310
1301
WX725
NOMESCO Finland
Noninvasive ventilation
5.3
38.2
123
252
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
8.0
37.9
88
116
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.2
37.3
150
387
G72.9
ICD-10 Finland
Myopathy, unspecified
16.6
36.7
59
37
G10
ICD-10 Finland
Huntington disease
+∞
36.6
35
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
36.6
309
1372
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.8
36.3
165
475
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.8
35.7
163
471
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.9
34.7
237
921
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
6.7
31.9
83
130
R1260
NOMESCO Finland
Evaluation of communicative skills
8.4
30.8
69
86
TJD20
NOMESCO Finland
Change of gastrostomy tube
21.1
30.6
45
22
XG466
NOMESCO Finland
Sleep oxymetry
5.0
29.9
99
209
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
56.3
28.2
33
6
34899
ICD-8 Finland
Motor neurone disease, Other and unspecified manifestations
+∞
26.1
25
*
N19
ICPC
Speech disorder
8.7
25.7
56
67
N18
ICPC
Paralysis/weakness
6.6
25.6
67
106
NXL00
NOMESCO Finland
Biopsy of muscle
32.7
24.7
32
10
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.1
24.6
101
264
D21
ICPC
Swallowing problem
9.4
24.1
50
55
N03AX12
ATC
gabapentin; oral
2.3
22.7
234
1123
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
8.3
22.0
49
61
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.2
21.8
86
217
R4190
NOMESCO Finland
Nutritional therapy
4.8
21.6
73
158
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.3
21.3
66
130
3342A
ICD-9 Finland
Spinocerebellar disease, Primary cerebellar degeneration
+∞
20.9
20
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
6.3
20.4
55
91
R5599
NOMESCO Finland
Other rehabilitation service
4.7
20.3
70
155
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.7
20.3
70
155
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
106.6
19.6
21
*
R26.0
ICD-10 Finland
Ataxic gait
31.8
19.3
25
8
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
10.0
19.2
38
39
04499
ICD-8 Finland
Late effects of actue poliomyelitis
70.9
18.7
21
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
10.0
18.7
37
38
R4120
NOMESCO Finland
Occupational therapy
2.9
18.6
116
418
R25.3
ICD-10 Finland
Fasciculation
16.4
18.4
29
18
G31.0
ICD-10 Finland
Circumscribed brain atrophy
19.6
18.2
27
14
SPAT1216
SPAT
Assessment of functional ability
2.0
18.2
246
1324
XG416
NOMESCO Finland
Measurement of maximal airway pressure
+∞
17.7
17
*
G12.0
ICD-10 Finland
Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]
+∞
17.7
17
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.6
17.4
135
556
XA402
NOMESCO Finland
ENMG
4.6
16.5
57
127
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
13.7
16.0
27
20
Z50.1
ICD-10 Finland
Other physical therapy
2.9
15.9
97
346
3352A
ICD-9 Finland
Anterior horn cell disease, Motor neuron disease[SCLEROSIS LATERALIS AMYOTROPHICA]
+∞
15.7
15
*
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.6
15.5
115
463
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
15.5
246
1399
M62.5
ICD-10 Finland
Muscle wasting and atrophy, not elsewhere classified
25.3
14.7
20
8
G11.00
ICD-10 Finland
Cerebellar dysplasia and aplasia
+∞
14.6
14
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
14.6
402
2729
XA800
NOMESCO Finland
Neuropsychological investigation
3.3
14.1
70
217
A98
ICPC
Health maint/preventive medicine
0.6
13.9
998
11165
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
5.4
13.8
41
78
Z50.5
ICD-10 Finland
Speech therapy
5.9
13.8
38
66
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
24.1
13.8
19
8
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
13.7
387
2631
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
13.6
375
2535
Z82.0
ICD-10 Finland
Family history of epilepsy and other diseases of the nervous system
26.0
13.4
18
7
N02AA01
ATC
morphine; systemic, rectal
5.4
13.2
39
74
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
15.2
13.1
21
14
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.3
13.0
48
116
G71.08
ICD-10 Finland
Other muscular dystrophy
28.7
13.0
17
6
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
13.0
226
1326
F80.1
ICD-10 Finland
Expressive language disorder
7.9
12.6
28
36
G11.18
ICD-10 Finland
Early-onset cerebellar ataxia
+∞
12.5
12
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.4
12.3
107
471
GX2D5
NOMESCO Finland
Sleep oximetry
26.9
12.1
16
6
RS314
NOMESCO Finland
NA
26.9
12.1
16
6
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
11.6
182
1023
T05
ICPC
Feeding problem of adult
12.7
11.6
20
16
TNX05
NOMESCO Finland
Simple incision of soft tissue, unspecified region
65.5
11.6
13
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.3
11.5
112
519
3343A
ICD-9 Finland
Spinocerebellar disease, Other cerebellar ataxia
+∞
11.5
11
*
AA1AD
NOMESCO Finland
CT of head and brain
1.6
11.5
320
2158
G82.1
ICD-10 Finland
Spastic paraplegia
121.0
11.4
12
*
G35
ICD-10 Finland
Multiple sclerosis
6.4
11.4
29
46
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
11.4
345
2374
G62.8
ICD-10 Finland
Other specified polyneuropathies
8.4
11.3
24
29
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
35.3
11.3
14
*
N81
ICPC
Injury nervous system other
25.2
11.1
15
6
SPAT1234
SPAT
Support of social functional capacity
2.5
10.9
84
347
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
18.0
10.7
16
9
N06AA09
ATC
amitriptyline; systemic
2.0
10.6
134
696
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.9
10.4
28
48
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
10.3
99
456
N70
ICPC
Poliomyelitis
23.5
10.2
14
6
A06AD11
ATC
lactulose; oral
1.7
10.2
212
1310
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.6
10.1
72
286
XX9TE
NOMESCO Finland
Compementary ultrasound examination
9.2
10.0
20
22
G60.0
ICD-10 Finland
Hereditary motor and sensory neuropathy
14.7
10.0
16
11
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
12.3
9.9
17
14
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
9.8
118
599
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
5.7
9.8
27
48
N05BA01
ATC
diazepam; systemic, rectal
1.8
9.8
174
1024
ABD40
NOMESCO Finland
Implantation of spinal injection device
55.4
9.7
11
*
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.4
9.6
78
332
L19
ICPC
Muscle symptom/complaint NOS
3.6
9.6
42
120
M41.4
ICD-10 Finland
Neuromuscular scoliosis
100.7
9.4
10
*
3349X
ICD-9 Finland
Spinocerebellar disease, unspecified
+∞
9.4
9
*
A210_
NOMESCO Finland
NA
+∞
9.4
9
*
G13.0
ICD-10 Finland
Paraneoplastic neuromyopathy and neuropathy
+∞
9.4
9
*
34898
ICD-8 Finland
Motor neurone disease, Alii definiti
+∞
9.4
9
*
3351X
ICD-9 Finland
Anterior horn cell disease, Spinal muscular atrophy[ATROPHIA MUSCULORUM SPINALIS NUD]
+∞
9.4
9
*
F02.29*G10
ICD-10 Finland
Dementia in Huntington's disease without information on additional symptoms
+∞
9.4
9
*
A120_
NOMESCO Finland
NA
+∞
9.4
9
*
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
9.3
140
779
RS340
NOMESCO Finland
NA
13.8
9.2
15
11
L99
ICPC
Musculoskeletal disease other
3.8
9.1
37
99
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
7.5
8.9
20
27
Z3226
NOMESCO Finland
Physiotherapist
1.6
8.9
235
1549
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
7.2
8.7
20
28
N05BA06
ATC
lorazepam; systemic, sublingual
2.4
8.7
75
328
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
8.3
8.6
18
22
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
16.4
8.6
13
8
Z2446
NOMESCO Finland
Social worker
2.1
8.5
89
429
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
6.4
8.5
21
33
G11
ICD-10 Finland
Hereditary ataxia
+∞
8.3
8
*
WX781
NOMESCO Finland
Remote monitoring, noninvasive ventilation
+∞
8.3
8
*
G11.02
ICD-10 Finland
Dysequilibrium syndrome
+∞
8.3
8
*
G82.2
ICD-10 Finland
Paraplegia, unspecified
10.8
8.3
15
14
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
14.6
8.2
13
9
N06AX21
ATC
duloxetine; oral
1.9
8.1
113
609
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
11.8
8.1
14
12
RS230
NOMESCO Finland
NA
9.0
8.0
16
18
Z73.6
ICD-10 Finland
Limitation of activities due to disability
6.6
7.9
19
29
RS221
NOMESCO Finland
NA
4.1
7.9
29
72
M54.1
ICD-10 Finland
Radiculopathy
2.6
7.8
54
211
N03AF01
ATC
carbamazepine; oral, rectal
2.2
7.8
74
340
N02AA05
ATC
oxycodone; systemic
1.6
7.8
194
1258
SPAT1167
SPAT
Insertion of urinary catheter
2.5
7.8
58
238
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.8
7.8
31
83
G71.3
ICD-10 Finland
Mitochondrial myopathy, not elsewhere classified
45.2
7.7
9
*
7812A
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Abnormality of gait
45.2
7.7
9
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.7
7.7
50
190
XKC03
NOMESCO Finland
Water cystometry
2.9
7.6
45
161
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
18.5
7.6
11
6
Z99.8
ICD-10 Finland
Dependence on other enabling machines and devices
18.5
7.6
11
6
Z93.1
ICD-10 Finland
Gastrostomy status
25.1
7.6
10
*
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
4.3
7.5
26
61
N05BA04
ATC
oxazepam; oral
1.5
7.5
278
1983
N06AB04
ATC
citalopram; systemic
1.5
7.4
245
1704
W19
ICD-10 Finland
Unspecified fall
1.9
7.4
115
646
R5110
SPAT
NA
3.0
7.3
40
137
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.7
7.3
47
177
G60.9
ICD-10 Finland
Hereditary and idiopathic neuropathy, unspecified
+∞
7.3
7
*
A220_
NOMESCO Finland
NA
+∞
7.3
7
*
34800
ICD-8 Finland
Motor neurone disease, Amyotrophic lateral sclerosis
+∞
7.3
7
*
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
3.6
7.3
31
88
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.0
7.3
27
68
Z3229
NOMESCO Finland
Other healthcare associate professional
1.8
7.3
120
690
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
4.5
7.3
24
54
RS142
NOMESCO Finland
NA
15.8
7.2
11
7
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
5.5
7.2
20
37
G61.8
ICD-10 Finland
Other inflammatory polyneuropathies
20.1
7.1
10
5
RS310
NOMESCO Finland
NA
20.1
7.1
10
5
SPAT1262
SPAT
Handing over of treatment supplies
1.5
7.1
231
1602
R42
ICD-10 Finland
Dizziness and giddiness
1.5
7.1
262
1868
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
4.0
7.0
26
66
U04
ICPC
Incontinence urine
2.2
6.9
64
294
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.1
6.9
71
342
G64
ICD-10 Finland
Other disorders of peripheral nervous system
13.8
6.9
11
8
XG410
NOMESCO Finland
Flow-volume spirometry
2.3
6.9
60
265
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
4.8
6.8
21
44
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.1
6.8
79
397
R49.08
ICD-10 Finland
Other specified dysphonia
3.2
6.6
32
101
R33
ICD-10 Finland
Retention of urine
1.8
6.6
114
663
N86
ICPC
Multiple sclerosis
7.8
6.6
14
18
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.0
6.6
75
377
N03AX16
ATC
pregabalin; oral
1.5
6.4
269
1965
N04BB01
ATC
amantadine; oral
3.7
6.4
26
72
RK110
NOMESCO Finland
NA
4.9
6.4
19
39
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
5.2
6.3
18
35
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
6.3
173
1148
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
6.3
161
2308
3350A
ICD-9 Finland
Anterior horn cell disease, Werdnig-Hoffmann disease[MORBUS WERDNIG-HOFFMANN]
+∞
6.3
6
*
G13.2*E03.9
ICD-10 Finland
Systemic atrophy primarily affecting central nervous system in myxoedema
+∞
6.3
6
*
UJC01
NOMESCO Finland
Scopy of lower throat
4.3
6.2
21
49
RS222
NOMESCO Finland
NA
3.6
6.2
26
74
A04
ICPC
Weakness/tiredness general
1.6
6.1
141
894
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
6.1
248
1797
N05BA09
ATC
clobazam; oral
8.6
6.1
12
14
RS122
NOMESCO Finland
NA
8.6
6.1
12
14
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.9
6.0
91
506

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
89
73
12.90
90.56
1.1
1.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
90
76
12.54
89.94
1.2
1.1
mg/l
37.4
41.7
0.29
74
64
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
88
74
12.58
88.15
1.1
1.1
mg/l
280.2
278.3
0.02
77
64
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
94
105
9.49
77.38
1.0
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
153
300
5.57
75.28
1.6
1.4
mg/l
590.1
525.4
0.22
147
278
(4027681)
70
59
12.40
69.87
1.3
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
93
117
8.41
69.65
1.0
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
78
81
10.11
67.67
1.1
1.1
nmol/l
0.1
5.1
1.36
11
15
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
94
127
7.83
66.28
1.0
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
678
3763
2.47
62.15
2.6
2.2
u/l
264.8
238.6
0.30
644
3519
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
219
662
3.71
61.70
1.3
1.3
au/ml
46.2
53.7
—
6
30
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
128
259
5.31
60.58
1.7
1.5
e6/l
7.0
43.2
0.90
106
203
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
127
259
5.27
59.56
1.8
1.6
e6/l
584.2
705.0
0.08
107
209
(3044290) Cell count panel - Cerebral spinal fluid
120
234
5.49
59.15
1.7
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
128
265
5.19
59.00
1.6
1.4
mmol/l
3.7
3.9
0.82
119
248
(3024869) Neuronal Ab [Presence] in Serum
43
24
18.42
53.49
1.1
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
56
58
9.99
48.55
1.1
1.1
u/l
1.0
1.1
0.53
24
31
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
56
60
9.66
47.36
1.1
1.5
u/l
5.3
9.0
0.66
45
47
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
214
887
2.65
34.10
4.9
4.8
mmol/l
2.8
1.8
3.27
193
667
(3009343) pH of Capillary blood
218
922
2.60
33.30
5.1
4.7
ph
7.4
7.4
2.72
30
109
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
219
935
2.57
32.79
5.2
4.7
kpa
5.5
5.1
7.37
212
872
(3019060) Gas panel - Arterial blood
201
881
2.48
28.27
3.8
5.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
203
924
2.39
26.19
2.1
2.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
231
1112
2.28
26.18
2.4
2.9
g/l
67.4
66.4
1.53
214
1008
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
975
11582
0.54
25.80
4.5
5.1
mmol/l
2.8
2.7
2.96
853
10557
(3016018) Differential panel - Cerebral spinal fluid
56
118
4.89
25.16
2.2
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
949
11334
0.55
24.97
4.2
4.6
mmol/l
4.7
4.5
2.68
842
10396
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
939
11236
0.56
24.61
4.2
4.6
mmol/l
1.4
1.4
0.68
835
10231
(3015235) Bicarbonate [Moles/volume] in Capillary blood
107
373
3.01
23.39
5.2
3.7
mmol/l
27.0
24.7
3.81
96
324
(3023410) Appearance of Cerebral spinal fluid
55
125
4.53
22.57
2.6
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
155
692
2.38
20.73
5.4
5.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
908
10814
0.59
20.51
6.1
6.2
mmol/mol
40.4
40.4
0.05
823
9922
(1616796) Gas panel - Central venous blood
88
296
3.10
20.46
4.6
3.9
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
29
39
7.56
20.40
1.3
1.3
nmol/l
159.9
124.1
0.35
21
29
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
963
11274
0.59
19.87
4.5
4.8
mmol/l
6.0
6.0
0.76
860
10160
(3021901) Oxygen saturation in Capillary blood
82
273
3.12
19.40
3.9
3.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
920
10870
0.60
19.25
3.8
4.1
mmol/l
1.3
1.3
0.58
816
9824
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
115
470
2.57
18.57
1.7
2.2
ug/l
912.1
475.0
0.28
107
442
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
261
1509
1.88
17.55
5.7
7.7
kpa
5.6
5.1
6.94
249
1445
(3027801) Oxygen [Partial pressure] in Arterial blood
260
1510
1.87
17.22
5.7
7.7
kpa
10.9
11.9
3.54
246
1446
(3003396) Base excess in Arterial blood by calculation
255
1513
1.83
15.67
5.6
7.7
mmol/l
3.0
1.2
10.96
210
1179
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
115
510
2.36
15.56
1.4
2.7
g/l
3.7
3.8
0.05
70
373
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
115
511
2.36
15.49
1.4
2.7
g/l
6.9
7.4
1.85
72
387
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
115
511
2.36
15.49
1.4
2.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
15
12
12.62
15.15
1.1
1.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
109
479
2.38
15.05
1.4
2.7
g/l
2.7
3.1
4.51
71
379
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
19
24
8.01
14.04
1.1
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
106
477
2.32
13.87
1.3
2.7
g/l
9.7
10.6
1.64
76
408
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
188
3132
0.54
13.73
1.8
1.7
mmol/l
1.4
1.4
0.17
164
2596
(3010813) Leukocytes [#/volume] in Blood
1169
12794
0.60
13.66
25.9
23.4
e9/l
6.9
6.8
0.49
1130
12373
(3000963) Hemoglobin [Mass/volume] in Blood
1170
12793
0.60
13.40
26.1
23.5
g/l
133.7
134.7
1.56
1150
12557
(3005719) IgG [Mass/volume] in Serum or Plasma
167
907
1.95
13.40
2.3
3.0
g/l
10.6
10.7
0.11
146
837
(3026361) Erythrocytes [#/volume] in Blood
1170
12791
0.60
13.35
25.9
23.3
e12/l
4.4
4.5
1.08
1130
12374
(3035941) MCH [Entitic mass]
1170
12790
0.60
13.32
25.8
23.2
pg
30.3
30.4
1.04
1148
12557
(3024731) MCV [Entitic volume]
1170
12789
0.60
13.29
25.8
23.3
fl
91.2
91.3
0.39
1148
12557
(3007461) Platelets [#/volume] in Blood
1170
12787
0.60
13.24
25.8
23.4
e9/l
251.3
244.0
3.51
1138
12417
(3008152) Bicarbonate [Moles/volume] in Arterial blood
155
836
1.95
12.68
6.2
7.7
mmol/l
26.3
24.6
4.83
145
784
(3044889) 12 lead EKG panel
695
8388
0.68
11.96
3.5
4.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
957
10862
0.67
11.86
16.3
14.8
ml/min/173m2
86.8
77.2
24.59
800
8976
(3012501) Base excess in Blood by calculation
71
294
2.49
11.20
6.0
4.7
mmol/l
3.5
2.7
1.52
64
200
(3010421) pH of Blood
79
351
2.32
10.68
5.9
4.4
ph
7.4
7.4
0.21
69
289
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
20
38
5.32
10.12
1.1
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
213
1352
1.67
10.07
6.0
8.1
%
94.5
95.4
0.85
204
1307
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1127
12285
0.66
10.00
11.3
10.9
u/l
27.7
26.1
1.72
1085
11813
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
20
39
5.18
9.85
1.1
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
263
3752
0.64
9.84
2.9
3.0
—
—
—
0
0
(3020891) Body temperature
103
526
2.03
9.84
4.6
4.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
27
68
4.03
9.79
1.9
2.9
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
98
493
2.06
9.75
1.7
1.9
u/l
38.4
38.9
0.09
89
431
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
14
19
7.43
9.71
1.2
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
83
402
2.13
9.13
5.4
7.7
mmol/l
1.2
1.4
0.34
70
351
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
19
40
4.80
8.60
1.2
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
12
6
20.15
8.47
1.1
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
344
2525
1.47
8.47
1.7
1.8
nmol/l
1151.9
1165.4
0.09
278
1888
(3024561) Albumin [Mass/volume] in Serum or Plasma
657
5432
1.37
8.15
4.6
5.0
g/l
35.3
35.0
0.60
614
5044
(3009542) Hematocrit [Volume Fraction] of Blood
926
10345
0.72
8.06
18.3
17.4
%
38.4
39.4
1.74
554
6958
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
198
2891
0.64
7.97
2.7
3.2
ug/l
0.8
0.8
0.22
138
1967
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
737
6224
1.36
7.92
7.1
7.2
mmol/l
1.2
1.2
3.25
625
5241
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
77
384
2.06
7.88
1.4
2.7
g/l
0.0
0.0
0.72
69
354
(3002385) Erythrocyte distribution width [Ratio]
843
9495
0.74
7.23
21.0
19.6
%
13.8
13.8
0.24
829
9259
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
18
42
4.33
7.22
1.2
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
61
288
2.17
7.21
2.7
2.5
%
18.1
15.9
4.25
46
151
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
43
4.23
7.02
1.2
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1113
11994
0.72
6.93
17.1
15.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
22
62
3.59
6.88
1.3
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
364
4615
0.72
6.72
2.1
2.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
278
2043
1.44
6.66
3.1
3.8
mmol/l
0.8
0.8
0.07
256
1907
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
81
440
1.89
6.54
1.4
2.9
g/l
0.4
1.4
2.97
70
385
(3020682) Albumin/Creatinine [Ratio] in Urine
306
3974
0.71
6.49
4.4
4.0
mg/mmol
16.0
8.6
0.92
201
2542
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
18
6.15
6.43
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
60
295
2.08
6.43
2.4
2.2
g/l
137.3
128.7
1.77
51
223
(3044927) Protein electrophoresis panel - Urine
38
154
2.51
6.38
1.5
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
293
2190
1.42
6.38
1.9
1.9
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
68
363
1.92
5.82
1.3
2.7
g/l
0.0
0.0
0.00
60
334
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
316
4020
0.73
5.77
4.2
4.5
%
21.9
21.8
0.02
159
2012
(3014111) Lactate [Moles/volume] in Serum or Plasma
167
1141
1.52
5.74
5.9
7.2
mmol/l
1.3
1.4
1.76
154
1093
(3009508) Creatinine [Moles/volume] in Urine
308
3929
0.73
5.71
4.3
3.2
mmol/l
7.3
7.5
0.56
252
3271
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
73
407
1.83
5.48
1.3
2.6
g/l
39.3
37.4
2.14
64
352
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
66
359
1.88
5.36
1.3
2.7
g/l
0.0
0.0
0.00
59
333
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
10
18
5.59
5.32
1.1
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
657
5680
1.28
5.14
6.7
6.5
mmol/l
1.2
1.2
1.42
596
5142
(3015171) Extractable nuclear Ab [Units/volume] in Serum
71
401
1.81
5.13
1.4
1.2
u/ml
7.3
1.1
—
6
28
(3023103) Potassium [Moles/volume] in Serum or Plasma
1142
12136
0.75
5.12
21.1
18.9
mmol/l
3.9
4.0
8.71
1114
11794
(3012516) Albumin [Mass/volume] in Urine
298
3762
0.74
5.05
3.4
3.3
mg/l
4142.5
290.4
4.42
200
2431
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
22
76
2.92
5.04
2.5
2.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
19
5.29
5.04
1.1
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
174
1237
1.46
4.93
6.7
8.6
g/l
130.7
121.4
8.38
169
1196
(3019550) Sodium [Moles/volume] in Serum or Plasma
1141
12107
0.75
4.84
21.2
18.7
mmol/l
139.5
139.6
0.58
1118
11782
(21494755) Public health laboratory ask at order entry panel
36
737
0.48
4.82
1.1
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
9
10
9.05
4.78
1.1
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
600
5170
1.27
4.70
2.0
2.1
pmol/l
93.4
93.6
0.04
331
2707
(3019977) pH of Arterial blood
21
74
2.86
4.66
1.7
3.4
ph
7.4
7.4
0.78
13
25
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
336
2691
1.32
4.62
1.6
1.7
pmol/l
68728982.5
21574374.3
0.47
291
2211
(3003338) MCHC [Mass/volume]
870
9527
0.79
4.60
23.0
20.9
g/l
331.8
332.4
0.93
856
9433
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
21
75
2.83
4.56
1.6
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
21
75
2.83
4.56
1.6
1.4
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
21
75
2.83
4.56
2.4
1.9
umol/l
28.0
98.7
—
5
7
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
529
0.41
4.50
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
561
6428
0.80
4.31
2.7
2.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
445
3731
1.27
4.28
3.7
3.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
166
1204
1.43
4.24
2.4
2.4
g/l
0.2
0.2
0.16
157
1119
(3023183) Ammonium ion [Moles/volume] in Plasma
55
307
1.82
4.18
2.9
3.0
umol/l
31.3
37.7
0.99
46
252
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
423
4984
0.79
4.07
4.4
5.2
ug/l
10.1
3.9
0.93
365
4425
(3002032) Base excess in Venous blood by calculation
171
1256
1.41
4.07
4.4
4.3
mmol/l
3.3
1.9
4.57
144
986
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
28
123
2.30
4.05
1.3
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
665
5877
1.24
3.97
5.8
6.0
e9/l
0.0
0.0
0.90
584
5058
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
83
528
1.61
3.96
1.9
2.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
27
120
2.27
3.81
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
45
791
0.56
3.78
1.6
1.8
—
—
—
0
0
(3012544) pH of Venous blood
174
1299
1.38
3.77
4.2
4.4
—
7.4
—
0
7
(3019198) Lymphocytes [#/volume] in Blood
675
5997
1.23
3.77
5.9
6.0
e9/l
1.9
1.9
0.10
596
5260
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
76
480
1.61
3.74
1.9
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
660
5857
1.23
3.70
5.8
5.9
e9/l
0.6
0.6
1.73
582
5029
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
65
396
1.67
3.69
1.5
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
191
1453
1.36
3.69
1.4
1.3
titre
660.0
455.5
0.70
48
309
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
11
30
3.69
3.64
1.0
1.6
%
—
17.0
—
0
5
(3023368) Bacteria identified in Blood by Culture
430
3651
1.25
3.62
4.4
4.5
—
—
—
0
0
(3002256) Pathology report gross observation
107
1518
0.68
3.59
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
16
397
0.40
3.58
1.1
1.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
679
6073
1.22
3.45
6.0
6.3
e9/l
0.2
0.2
1.52
604
5313
(42870588) Differential panel, method unspecified - Blood
471
4070
1.23
3.34
5.1
6.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
16
59
2.73
3.32
1.6
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
15
54
2.80
3.26
1.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
323
0.37
3.25
1.1
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
14
49
2.87
3.19
1.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
15
5.36
3.19
1.1
1.3
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
7
11
6.39
3.18
1.0
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
19
79
2.42
3.14
1.3
1.4
promille
1.5
1.2
0.30
14
60
(3022096) Basophils/100 leukocytes in Blood
606
5397
1.21
3.13
5.4
6.2
%
0.6
0.7
0.68
571
5013
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
126
924
1.40
3.07
1.7
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
229
0.35
3.06
1.3
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
34
3.25
3.06
1.1
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
131
1744
0.73
3.05
1.2
1.2
u/ml
5.6
13.3
1.79
51
640
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
7
12
5.85
3.02
1.1
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
790
7227
1.20
3.01
5.5
5.1
mmol/l
6.7
6.8
0.33
745
6796
(3026389) Candida sp identified in Specimen by Organism specific culture
26
127
2.07
2.98
1.3
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
97
685
1.45
2.92
6.9
9.6
mmol/l
25.8
24.4
4.15
89
644
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
32
170
1.90
2.92
1.0
1.1
iu/ml
22.4
85.7
0.72
14
32
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
9
6.69
2.87
1.2
2.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1105
11596
0.82
2.86
19.1
16.1
mg/l
26.3
26.0
0.09
937
9310
(3026493) Urate [Moles/volume] in Serum or Plasma
269
3222
0.80
2.83
3.3
2.9
umol/l
5888.4
6610.3
0.09
233
2771
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
92
649
1.45
2.80
4.6
5.1
mmol/l
25.5
24.0
3.79
79
593
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
15
59
2.56
2.79
1.6
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
97
694
1.43
2.74
9.3
11.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
7
14
5.02
2.73
1.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
72
2.38
2.73
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
16
66
2.44
2.71
1.1
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
617
5568
1.18
2.63
6.2
6.5
%
8.4
8.8
3.64
583
5184
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
193
1547
1.28
2.61
1.8
1.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
613
5545
1.18
2.51
5.7
6.2
%
2.6
2.9
1.93
579
5134
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
54
350
1.56
2.48
2.1
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
142
1102
1.32
2.45
8.2
8.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
96
1294
0.72
2.45
1.3
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
416
3647
1.20
2.43
3.8
4.1
ph
7.4
7.4
0.14
70
704
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
12
5.02
2.40
1.2
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
13
52
2.51
2.36
1.2
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
47
2.57
2.27
1.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
23
3.49
2.27
1.0
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
177
1431
1.27
2.25
2.0
1.7
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
17
79
2.17
2.25
2.2
2.2
%
12.9
13.4
—
10
41
(3027273) Bicarbonate [Moles/volume] in Venous blood
88
647
1.38
2.18
3.9
3.3
mmol/l
26.0
25.1
1.25
82
623
(40761535) Cells panel - Urine sediment
132
1033
1.30
2.17
4.3
3.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
103
1345
0.75
2.15
3.1
4.2
ug/l
14.0
22.1
0.39
83
1123
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
20
372
0.53
2.15
1.7
1.7
mg/l
1.4
2.8
1.59
11
278
(3038026) Centromere Ab [Units/volume] in Serum
19
95
2.01
2.11
1.1
1.1
—
89.0
—
0
5
(3003181) Sodium [Moles/volume] in Urine
38
237
1.62
2.09
1.6
1.4
mmol/l
57.7
63.3
0.36
27
195
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
31
2.91
2.07
4.3
2.9
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
10
5.01
2.07
1.2
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
48
707
0.67
2.04
1.2
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
620
5681
1.16
2.04
5.7
6.3
%
26.1
27.1
1.40
584
5268
(3032080) INR in Blood by Coagulation assay
579
5280
1.16
2.03
10.2
10.6
inr
1.3
1.3
0.57
144
1479
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
85
1131
0.74
2.03
1.5
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
13
272
0.47
2.00
2.5
2.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
421
3753
1.17
1.98
3.7
3.3
u/l
33.2
38.6
0.61
403
3566
(3037756) Immunofixation for Serum or Plasma
45
297
1.53
1.97
2.0
1.7
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
27
2.97
1.93
1.3
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
33
519
0.63
1.92
1.2
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
16
78
2.06
1.91
1.5
2.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
31
492
0.62
1.88
3.0
3.3
u/ml
6303.0
8361.1
0.09
25
414
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
96
1240
0.76
1.88
1.4
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
187
1556
1.23
1.87
1.8
1.8
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
28
2.87
1.86
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
28
2.87
1.86
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
28
2.87
1.86
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
28
2.87
1.86
1.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
17
3.54
1.84
1.2
3.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
20
108
1.86
1.82
2.1
2.2
e9/l
1.3
1.0
0.49
15
60
(3008295) Osmolality of Serum or Plasma
24
138
1.75
1.80
1.5
1.5
mosm/kgh2o
269.9
278.6
0.92
17
99
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
55
767
0.71
1.78
1.3
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
80
603
1.35
1.75
4.2
3.1
%
0.7
0.6
0.65
74
585
(3018010) Neutrophils/100 leukocytes in Blood
605
5585
1.14
1.72
5.6
6.1
%
58.6
57.7
0.94
574
5203
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
13
3.85
1.71
1.8
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
100
1266
0.77
1.70
2.6
2.3
ug/g
134.0
137.8
0.06
76
1005
(4133840)
7
25
2.81
1.65
1.7
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
341
3038
1.16
1.60
1.6
1.6
nmol/l
20.1
20.5
0.18
305
2569
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
23
136
1.70
1.59
3.0
2.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
204
1745
1.20
1.57
5.9
6.2
mmol/l
1.1
1.0
0.34
189
1601
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
78
1.93
1.54
1.1
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
72
547
1.33
1.52
4.8
6.3
%
1.5
1.6
0.86
64
516
(3003740) Influenza virus B Ag [Presence] in Specimen
6
141
0.42
1.52
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
142
0.42
1.52
1.0
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
48
341
1.42
1.52
1.5
1.6
iu/ml
0.3
19.1
0.49
15
63
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1008
10486
0.88
1.51
4.6
4.6
mu/l
1.9
2.1
1.02
922
9459
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
45
0.00
1.50
0.0
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
18
101
1.79
1.49
1.2
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
38
260
1.47
1.47
1.4
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
41
285
1.45
1.46
1.3
1.2
u/ml
2.0
9.1
—
9
44
(4094501)
19
316
0.60
1.45
1.2
1.1
—
—
—
0
0
(4010399)
106
855
1.26
1.44
1.3
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
21
125
1.69
1.44
2.3
2.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
59
2.04
1.43
2.4
4.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
516
4760
1.13
1.43
2.4
2.3
nmol/l
77.3
77.6
0.10
456
4196
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
133
1594
0.82
1.43
1.3
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
23
142
1.63
1.38
1.1
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
17
2.95
1.36
1.2
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
38
0.00
1.34
0.0
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
208
1.50
1.33
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
42
300
1.41
1.32
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
42
300
1.41
1.32
1.3
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
76
960
0.78
1.32
2.2
2.2
nmol/l
13.2
13.0
0.04
62
838
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
31
209
1.49
1.30
1.4
1.2
u/ml
38.7
29.9
—
5
16
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
50
668
0.74
1.30
1.7
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
102
832
1.24
1.29
1.8
1.6
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
18
2.78
1.28
1.4
1.3
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
10
48
2.09
1.28
3.0
2.4
%
9.4
11.7
—
10
43
(3007930) Methemoglobin/Hemoglobin.total in Blood
69
537
1.30
1.27
4.6
6.3
%
0.9
0.9
0.25
62
507
(1002224) Polysomnography panel
26
388
0.66
1.27
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
286
2559
1.15
1.27
4.7
4.0
kg/l
1.0
1.0
0.01
55
381
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
35
2.29
1.27
1.3
2.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
39
278
1.41
1.25
1.2
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
61
468
1.32
1.25
4.5
3.4
g/l
0.3
0.3
0.00
24
190
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
265
2365
1.15
1.22
1.2
1.3
u/ml
1.5
1.8
0.10
65
599
(3013650) Neutrophils [#/volume] in Blood by Automated count
721
6826
1.11
1.22
7.7
9.4
e9/l
4.2
4.2
0.08
630
5957
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
39
281
1.40
1.19
1.3
1.2
u/ml
2.8
2.7
—
7
26
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
211
0.57
1.17
2.7
3.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
34
0.00
1.16
0.0
8.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
20
2.50
1.15
2.6
2.9
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
20
2.50
1.15
1.4
1.3
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
20
2.50
1.15
5.2
5.7
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
35
0.00
1.15
0.0
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
24
158
1.53
1.15
1.3
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
536
5720
0.90
1.15
5.9
5.1
estimate
0.0
0.0
0.00
102
1094
(3034426) Prothrombin time (PT)
0
36
0.00
1.14
0.0
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
36
0.00
1.14
0.0
8.1
—
—
—
0
0
(4034850)
49
370
1.34
1.14
7.8
11.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
40
2.01
1.12
1.4
1.1
miu/ml
2107.9
1654.1
—
8
40
(3019225) pH of Specimen
146
1254
1.18
1.12
5.0
4.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
59
750
0.78
1.11
1.7
1.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
170
1481
1.17
1.10
3.0
4.1
u/l
220.0
249.8
3.38
162
1398
(46235355) HIV 1 and 2 tests - Meaningful Use set
173
1510
1.16
1.09
1.5
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
26
177
1.48
1.08
2.8
2.8
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
32
2.19
1.08
1.3
1.8
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
15
89
1.69
1.07
1.0
1.0
ng/l
33.5
44.3
—
10
48
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
12
67
1.80
1.04
2.0
2.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
94
1125
0.82
1.04
3.4
2.4
u/l
30.6
80.9
0.62
78
951
(40761536) Microorganisms panel - Urine sediment
85
1027
0.82
1.04
4.8
3.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
46
1.96
1.03
1.4
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
93
773
1.22
1.03
3.5
3.2
e9/l
4.2
4.1
0.12
69
589
(3039443) Prostate specific Ag panel - Serum or Plasma
15
239
0.62
1.02
1.6
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
202
0.59
1.02
1.2
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
83
1.69
1.01
1.7
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
488
5204
0.91
1.01
9.7
10.3
e9/l
0.0
0.0
1.16
395
4244
(3009261) Glucose [Presence] in Urine by Test strip
547
5798
0.91
0.99
4.5
3.8
estimate
0.0
0.0
0.80
96
1057
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
133
0.52
0.99
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
38
503
0.75
0.98
2.3
1.9
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
14
84
1.67
0.98
2.9
3.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
29
0.00
0.97
0.0
9.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
540
5723
0.91
0.97
4.4
3.7
estimate
0.0
0.0
0.00
98
1088
(3008898) HLA-B27 [Presence]
23
330
0.69
0.97
1.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
31
0.00
0.96
0.0
2.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
37
1.90
0.94
1.3
2.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
27
2.23
0.93
1.3
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
22
315
0.69
0.92
4.2
3.2
nmol/l
0.9
0.8
0.05
17
245
(3036481) Cortisol [Moles/volume] in Serum or Plasma
124
1074
1.17
0.89
2.1
2.2
nmol/l
376.9
365.5
0.28
110
990
(3003694) ABO and Rh group [Type] in Blood
278
3032
0.90
0.89
1.3
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
153
0.59
0.88
1.0
1.4
—
—
—
0
0
(4198724)
6
30
2.00
0.87
1.8
1.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
27
368
0.73
0.87
1.2
1.5
ug/g
236.7
280.5
0.62
18
218
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
481
0.76
0.87
3.1
3.8
u/ml
0.4
0.3
0.23
21
282
(3001122) Ferritin [Mass/volume] in Serum or Plasma
459
4878
0.91
0.86
2.8
2.8
ug/l
162.6
147.2
0.33
420
4432
(3003327) Ova and parasites identified in Stool by Light microscopy
23
322
0.71
0.86
1.4
1.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
45
1.78
0.84
3.5
2.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
113
0.53
0.83
1.2
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
20
284
0.70
0.82
1.3
1.3
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
14
89
1.58
0.81
1.0
1.0
ng/l
797.9
597.1
—
8
50
(4035726)
90
1052
0.85
0.81
1.3
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
367
3927
0.91
0.80
2.7
3.1
ng/l
1516.7
1625.8
0.13
302
3358
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
163
1822
0.88
0.80
1.3
1.3
iu/ml
36.8
35.4
0.04
43
572
(3000330) Specific gravity of Urine by Test strip
52
640
0.81
0.80
4.2
3.8
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
33
1.82
0.79
1.0
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
52
638
0.81
0.78
1.2
1.3
u/ml
359.8
207.2
0.61
47
581
(3000285) Sodium [Moles/volume] in Blood
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
27
0.00
0.77
0.0
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
27
0.00
0.77
0.0
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
268
0.71
0.76
1.3
1.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
18
124
1.46
0.75
4.9
2.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
91
784
1.17
0.73
1.6
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
815
7877
1.08
0.73
5.7
4.6
e6/l
79.1
2128.7
1.99
13
131
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
117
1031
1.15
0.71
2.8
3.8
mmol/l
1.2
1.2
0.52
95
893
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
182
0.66
0.71
4.4
2.5
u/ml
4.7
28.5
0.57
12
174
(40760892) CBC W Ordered Manual Differential panel - Blood
266
2460
1.10
0.71
4.5
4.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
67
565
1.19
0.70
2.4
2.0
ug/l
0.6
2.1
2.00
59
496
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
129
1148
1.14
0.68
2.6
3.3
ng/l
163.4
224.2
0.93
123
1056
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
144
1.39
0.68
1.4
1.9
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
5
28
1.79
0.66
1.0
1.3
—
216.4
—
0
5
(4015189)
7
44
1.59
0.65
2.6
2.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
25
189
1.33
0.64
2.2
2.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
60
708
0.84
0.64
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
289
3091
0.92
0.63
3.9
3.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
129
1433
0.89
0.61
1.5
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
17
122
1.40
0.60
1.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
17
122
1.40
0.60
1.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
17
122
1.40
0.60
1.1
1.7
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.7
—
2.1
—
0
9
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
34
272
1.26
0.60
1.2
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
72
1.53
0.59
1.1
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
72
1.53
0.59
1.1
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
72
1.53
0.59
1.1
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
72
1.53
0.59
1.1
1.9
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
35
1.72
0.57
1.2
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
36
1.67
0.56
2.0
4.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
16
115
1.40
0.56
1.1
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
126
1394
0.89
0.56
3.5
3.1
umol/l
7.1
8.4
0.55
107
1226
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
139
1261
1.11
0.56
1.9
1.7
%
1.6
1.5
0.19
124
1082
(36660697) Celiac disease serology panel - Serum
97
861
1.14
0.56
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
42
504
0.83
0.55
1.5
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
124
0.64
0.54
1.1
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
14
99
1.42
0.54
1.3
1.3
u/l
11.8
13.8
0.70
14
93
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
61
1.48
0.53
1.3
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
68
591
1.16
0.53
2.4
3.3
pmol/l
4.3
4.5
0.62
60
517
(3000012) Reticulocyte production index
9
62
1.45
0.53
1.3
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
148
1355
1.10
0.51
4.4
3.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
253
2694
0.93
0.51
4.7
3.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
27
336
0.80
0.51
1.9
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
360
3784
0.94
0.51
3.1
2.5
u/l
53.4
57.1
1.27
336
3483
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
10
145
0.69
0.50
1.1
1.2
nmol/l
0.7
0.6
—
10
136
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
31
379
0.81
0.50
1.5
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
84
1.43
0.49
1.1
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
45
1.56
0.49
1.9
1.7
—
—
—
0
0
(4281824)
7
108
0.65
0.48
1.0
1.2
—
—
—
0
0
(4268621)
7
111
0.63
0.48
2.1
2.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
221
0.77
0.46
1.1
1.3
miu/ml
279.8
212.4
—
8
91
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
81
0.62
0.46
3.2
1.5
g/l
0.8
1.0
—
5
81
(3013512) EKG study
350
3667
0.94
0.45
4.1
4.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
50
1.40
0.45
1.1
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
12
86
1.40
0.44
2.1
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
16
121
1.33
0.44
1.1
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
37
312
1.19
0.43
1.1
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
239
2531
0.93
0.43
1.8
1.9
mg/l
1.4
1.3
0.06
185
1963
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
91
0.66
0.42
1.3
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
57
1.41
0.42
1.1
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
57
1.41
0.42
1.1
2.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.4
—
7.3
—
0
9
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
81
729
1.12
0.41
1.9
1.8
g/l
1.3
1.4
0.36
72
672
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
16
0.00
0.41
0.0
1.8
—
7.8
—
0
7
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
14
105
1.34
0.41
6.2
1.8
mg/l
2.3
4.4
3.76
14
100
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
83
918
0.90
0.40
3.3
4.0
%
1.5
0.6
0.53
23
230
(3000492) Spirometry study
94
1032
0.90
0.40
1.7
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
308
3225
0.94
0.40
2.2
2.2
mg/l
3.1
3.0
0.25
260
2721
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
61
1.31
0.39
1.3
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
97
1.34
0.39
1.0
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
104
0.67
0.39
1.1
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.0
1.6
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
7
105
0.67
0.39
1.0
1.4
—
33.6
—
0
7
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.0
—
26.2
—
0
19
(3009466) Valproate [Moles/volume] in Serum or Plasma
22
178
1.24
0.39
5.2
5.1
umol/l
380.6
358.8
0.22
17
160
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
170
0.76
0.38
1.3
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
56
631
0.88
0.38
1.8
1.9
g/l
1.5
1.5
0.30
51
553
(3004789) Transferrin [Mass/volume] in Serum or Plasma
174
1852
0.93
0.37
2.5
2.5
g/l
2.2
2.3
0.75
158
1713
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
98
1.33
0.37
1.3
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
8
112
0.71
0.37
1.4
1.1
%
96.4
94.8
—
8
106
(3024932) HLA-DR beta [Type]
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
282
2691
1.06
0.37
3.3
2.7
e6/l
6.3
5.2
0.51
253
2379
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
116
0.69
0.37
1.1
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
653
6367
1.05
0.36
5.8
6.4
umol/l
11.9
12.1
0.09
620
6034
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
54
479
1.13
0.36
1.9
2.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
42
1.43
0.35
2.3
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
42
1.43
0.35
2.3
2.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
25
208
1.21
0.35
2.0
1.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
13
167
0.78
0.34
1.2
1.1
g/l
1.6
1.5
0.86
13
151
(3005033) Fetal Nuchal fold Thickness US
6
88
0.68
0.33
1.3
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
88
0.68
0.33
1.3
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
173
1.22
0.33
8.4
3.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
55
613
0.89
0.33
1.4
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
51
571
0.89
0.33
2.9
2.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
19
231
0.82
0.32
1.3
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
30
349
0.86
0.32
1.4
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
238
1.18
0.32
1.5
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
19
155
1.23
0.32
1.7
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
155
1.23
0.32
1.8
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
155
1.23
0.32
1.8
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
18
146
1.24
0.32
1.1
1.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
13
101
1.29
0.31
1.2
1.2
u/l
8.8
14.0
0.88
13
92
(3032773) Endomysium IgG Ab [Titer] in Serum
13
101
1.29
0.31
1.1
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
803
8174
0.96
0.31
5.1
4.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
19
156
1.22
0.31
1.8
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
424
4371
0.96
0.30
4.7
3.9
e6/l
81.8
125.0
0.91
332
3220
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
100
0.70
0.30
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
100
0.70
0.30
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
100
0.70
0.30
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
100
0.70
0.30
1.3
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
22
184
1.20
0.30
2.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
42
372
1.13
0.30
1.5
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
188
1787
1.06
0.30
23.3
27.4
inr
1.1
1.4
1.99
25
241
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
157
1.21
0.29
1.8
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
157
1.21
0.29
1.8
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
106
0.75
0.29
1.4
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
107
0.75
0.29
1.5
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
108
0.74
0.29
2.3
2.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
39
345
1.13
0.28
1.5
1.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
39
345
1.13
0.28
1.5
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
545
5581
0.96
0.28
3.7
4.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
72
783
0.92
0.28
3.1
3.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
224
2144
1.05
0.28
1.4
1.5
g/l
2.4
2.6
0.58
136
1266
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
45
500
0.90
0.27
1.1
1.0
—
—
—
0
0
(4306422)
12
150
0.80
0.27
1.4
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
160
1520
1.06
0.26
9.0
7.6
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
13
104
1.25
0.26
1.1
1.4
u/l
28.1
27.8
0.01
13
80
(3035637) Corticotropin [Mass/volume] in Plasma
18
150
1.20
0.26
1.4
1.5
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
8
67
1.20
0.26
1.1
1.2
u/l
73.6
88.9
—
8
61
(3044242) Glucose [Moles/volume] in Arterial blood
10
77
1.30
0.26
1.8
2.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
74
0.67
0.26
6.2
3.7
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
23
267
0.86
0.26
2.7
3.6
u/ml
482.0
1430.7
0.44
23
251
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
32
362
0.88
0.25
2.3
3.9
%
90.3
89.4
0.06
32
345
(3045788) Cell count panel - Pleural fluid
11
138
0.80
0.25
1.2
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
9
73
1.23
0.25
1.3
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
21
245
0.86
0.25
1.3
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
198
2066
0.95
0.25
3.7
3.2
e6/l
2.9
1.9
0.51
131
1187
(3042111) Morphology [Interpretation] in Bone marrow Narrative
20
234
0.85
0.25
1.5
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
26
297
0.87
0.24
1.3
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
81
0.74
0.24
1.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
84
0.71
0.24
1.5
1.8
—
—
—
0
0
(3024471) HLA-A [Type]
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
119
1256
0.94
0.23
1.5
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
136
0.81
0.23
1.1
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
18
211
0.85
0.23
5.6
3.8
%
2.9
1.3
0.59
18
172
(40758558) Short blood count panel - Blood
308
2988
1.04
0.23
5.6
7.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
39
1.28
0.23
6.0
2.6
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
40
1.25
0.22
1.0
2.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
31
347
0.89
0.22
4.3
3.6
g/l
3.0
3.6
1.32
31
327
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
848
8588
0.97
0.22
3.8
3.8
pmol/l
15.2
14.9
3.04
779
7689
(3051611) Lipemic interference index of Serum or Plasma
10
124
0.81
0.21
2.3
3.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
10
0.00
0.21
0.0
4.0
—
124.7
—
0
10
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
156
0.83
0.21
1.8
4.6
—
—
—
0
0
(4212803)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
103
0.78
0.21
1.1
5.3
%
10.1
10.9
—
8
103
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
5
43
1.16
0.21
1.0
2.0
ug/l
14.7
220.7
—
5
34
(3027944) Amphetamines [Presence] in Urine
21
240
0.87
0.20
4.4
2.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
723
7333
0.97
0.20
3.7
3.3
u/l
47.2
52.9
0.65
672
6775
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
168
1748
0.96
0.20
2.5
2.6
%
23.5
22.6
0.40
146
1490
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
102
967
1.06
0.20
4.5
4.1
ng/l
97.0
93.1
0.15
90
838
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
50
1.20
0.19
1.8
1.1
iu/ml
115.0
185.1
—
6
50
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
30
333
0.90
0.19
2.8
2.4
ug/min
95.1
84.7
0.05
17
204
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
186
0.86
0.19
1.8
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
476
4851
0.97
0.19
4.5
3.9
ng/l
48.1
62.3
0.48
390
3571
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
81
1.24
0.18
1.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
156
1.16
0.18
1.1
1.1
—
—
—
0
0
(4062490)
13
109
1.19
0.18
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
61
570
1.07
0.18
1.3
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
58
1.21
0.18
1.1
2.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
177
1833
0.96
0.18
1.8
2.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
392
3841
1.03
0.17
2.3
2.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
7
63
1.11
0.17
7.3
18.8
nmol/l
1389.9
1529.3
—
7
63
(3024263) Appearance of Synovial fluid
5
66
0.76
0.17
1.0
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
69
0.72
0.17
1.2
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
26
288
0.90
0.16
1.4
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
139
1.15
0.16
2.8
4.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
183
0.87
0.16
1.1
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
78
0.77
0.15
2.5
1.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
206
2002
1.03
0.15
2.6
2.4
s
29.6
30.0
0.58
199
1942
(1617658) Protocol used for examination of sentinel lymph nodes
6
80
0.75
0.15
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
10
83
1.21
0.15
1.4
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
262
2559
1.03
0.14
3.6
2.9
mosm/kgh2o
528.9
556.2
1.24
226
2186
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
253
2470
1.03
0.14
3.8
4.0
ng/l
546.8
406.6
0.15
204
2029
(3035320) C reactive protein [Mass/volume] in Body fluid
9
83
1.08
0.14
2.4
2.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
425
4180
1.02
0.14
2.7
3.5
mmol/l
2.4
2.3
1.68
369
3606
(3020961) Endomysium IgA Ab [Titer] in Serum
46
491
0.93
0.14
1.0
1.1
—
165.5
—
0
12
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
227
1.10
0.14
3.4
3.2
e9/l
4.3
4.4
0.08
25
227
(40768797) Stomach Pathology biopsy report
162
1670
0.97
0.14
1.2
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
288
2941
0.97
0.14
2.3
2.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
149
0.87
0.13
1.1
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
180
1.11
0.13
1.6
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
28
304
0.92
0.13
1.7
1.7
e6/l
14242.3
17135.9
0.13
20
223
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
117
0.85
0.13
1.9
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
108
0.83
0.13
1.1
1.1
—
—
—
0
0
(44806118)
18
161
1.12
0.13
1.4
1.7
—
—
—
0
0
(44790049)
18
161
1.12
0.13
1.4
1.7
—
—
—
0
0
(44790047)
18
161
1.12
0.13
1.4
1.7
—
—
—
0
0
(44790048)
18
161
1.12
0.13
1.4
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
18
200
0.90
0.12
1.3
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
210
0.90
0.12
1.6
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
158
0.88
0.12
1.2
1.2
u/ml
1.7
4.9
—
6
73
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
20
181
1.11
0.12
5.1
7.2
mg/l
11.7
12.1
0.13
20
167
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
244
2391
1.02
0.11
2.7
3.1
mmol/l
2.5
2.5
1.02
205
2082
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
436
4419
0.98
0.11
4.7
4.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
16
178
0.90
0.11
3.6
2.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
32
342
0.93
0.11
1.6
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
29
311
0.93
0.10
2.0
2.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
92
951
0.97
0.10
3.8
4.3
%
0.1
0.1
0.08
28
289
(3036489) Thrombin time
46
437
1.05
0.10
2.0
2.9
s
20.6
21.8
1.23
38
394
(1761482) Bacteria [#/volume] in Urine by Culture
37
349
1.06
0.10
4.2
4.9
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
46
1.09
0.09
1.2
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
119
1158
1.03
0.09
2.3
2.7
e9/l
66.2
69.7
0.64
97
897
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
213
1.08
0.09
1.2
1.3
u/ml
276.2
285.3
0.08
13
118
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
21
227
0.92
0.09
1.5
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
30
319
0.94
0.09
4.5
3.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
32
339
0.94
0.08
1.6
1.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
6
57
1.05
0.08
44.5
30.0
ug/l
5.8
6.7
—
6
49
(3009214) Lutropin [Units/volume] in Serum or Plasma
27
253
1.07
0.08
1.2
1.4
u/l
11.3
8.9
0.37
21
198
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
12
107
1.12
0.08
1.1
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
144
0.90
0.08
1.2
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
7
64
1.09
0.08
1.3
1.5
—
11.7
—
0
5
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
7
64
1.09
0.08
1.1
1.2
u/l
13.3
17.9
—
7
57
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
18
195
0.92
0.08
2.5
3.8
—
503.0
—
0
19
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
27
254
1.06
0.07
1.5
1.8
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
18
166
1.09
0.07
1.9
2.4
mg/l
29.2
24.9
—
6
40
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
35
333
1.05
0.07
1.5
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
78
1.03
0.07
1.9
3.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
81
0.86
0.07
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
81
0.86
0.07
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
81
0.86
0.07
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
147
1498
0.98
0.07
4.0
4.7
%
32.0
32.5
0.21
98
991
(3022948) Iron [Moles/volume] in Serum or Plasma
198
2011
0.98
0.07
2.5
2.6
umol/l
13.1
12.7
0.29
177
1861
(1001926) Buprenorphine [Presence] in Urine by Screen method
21
196
1.07
0.07
4.0
2.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
17
157
1.08
0.07
1.2
1.4
e6/l
15612.5
114753.8
1.47
12
95
(3030467) Casts [#/volume] in Urine by Automated count
354
3504
1.01
0.07
3.9
3.3
e6/l
0.4
0.5
0.30
285
2697
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
32
336
0.95
0.06
1.6
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
95
0.84
0.06
1.0
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
25
236
1.06
0.06
3.8
3.5
%
61.3
59.1
0.45
25
236
(21494890) Protein electrophoresis panel - 24 hour Urine
15
138
1.09
0.06
1.9
2.3
—
—
—
0
0
(4024509)
9
102
0.88
0.06
2.0
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
103
0.87
0.06
1.6
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
922
9256
0.99
0.06
7.6
7.7
u/l
77.7
80.1
0.84
864
8670
(3024928) Oxygen saturation in Venous blood
28
294
0.95
0.06
3.3
4.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
20
188
1.06
0.05
1.3
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
335
3379
0.99
0.05
3.7
3.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
11
100
1.10
0.05
1.1
1.0
u/ml
4.0
6.1
—
5
39
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
37
357
1.04
0.04
6.9
5.4
mg/l
1.6
1.6
0.17
37
326
(4146454)
15
140
1.07
0.04
1.9
2.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
140
1.07
0.04
1.1
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
868
8652
1.01
0.04
4.4
4.2
mm/h
12.5
13.2
0.77
805
7931
(3016879) Cocaine [Presence] in Urine
24
229
1.05
0.04
4.0
2.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
219
2169
1.01
0.04
3.3
2.9
e6/l
1.0
1.0
0.18
151
1282
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
229
0.96
0.03
1.4
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
25
241
1.04
0.02
3.9
2.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
16
152
1.05
0.02
1.4
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
31
319
0.97
0.02
1.3
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
33
321
1.03
0.02
1.1
1.2
—
5.4
—
0
5
(3051387) C reactive protein [Mass/volume] in Capillary blood
27
278
0.97
0.02
5.8
3.6
mg/l
23.2
27.3
0.34
16
183
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
16
153
1.05
0.01
1.3
1.6
%
39.6
64.8
—
8
97
(3027945) Reticulocytes/100 erythrocytes in Blood
154
1550
0.99
0.01
2.2
2.7
%
1.7
1.8
0.48
138
1368
(3033658) Prothrombin time (PT) actual/Normal
308
3090
1.00
0.01
5.2
4.3
%
87.7
86.6
0.38
302
3010
(3025159) Blasts/100 leukocytes in Blood
89
898
0.99
0.01
3.7
4.3
%
0.0
0.5
0.60
25
246
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
95
942
1.01
0.01
3.7
2.9
ml/min/173m2
77.1
63.5
0.39
37
398
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
146
0.96
0.00
1.2
1.1
u/ml
1.8
1.6
—
7
64
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
194
1.03
0.00
1.5
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
224
1.03
0.00
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
25
244
1.03
0.00
3.9
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24
246
0.98
0.00
2.0
2.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
67
664
1.01
0.00
2.6
2.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
18
184
0.98
0.00
1.3
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
43
434
0.99
0.00
3.7
3.6
mg/l
29.2
54.2
1.05
35
357
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
117
1166
1.00
0.00
2.8
2.5
ug/l
7.6
7.0
0.07
104
1009
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
62
618
1.00
0.00
1.1
1.2
iu/ml
159.6
155.5
0.02
17
249
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
21
211
1.00
0.00
1.7
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
24
239
1.00
0.00
1.5
1.8
iu/l
5.5
5.7
—
9
78
(3017143) Hepatitis C virus Ab [Presence] in Serum
111
1112
1.00
0.00
1.5
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
38
381
1.00
0.00
3.1
3.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
313
3128
1.00
0.00
5.1
4.0
estimate
0.0
0.0
0.69
98
1041
(3012441) Differential panel - Pleural fluid
15
147
1.02
0.00
1.1
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
17
167
1.02
0.00
1.7
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
18
183
0.98
0.00
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
24
243
0.99
0.00
4.0
2.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
43
433
0.99
0.00
3.7
3.7
mg/l
45.8
68.4
0.74
36
355
(3002582) Erythrocytes [#/volume] in Urine
384
3835
1.00
0.00
4.2
3.5
e6/l
45.0
87.1
1.24
309
3016
(3017181) Myelocytes/100 leukocytes in Blood
102
1015
1.01
0.00
3.6
4.2
%
1.3
0.9
0.66
33
317
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
115
0.96
0.00
1.8
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
155
1.03
0.00
1.2
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(3013862) HLA-DP [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
8
87
0.92
0.00
1.3
2.3
nmol/l
12.5
19.0
—
8
79
(3036525) Urea [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
93
0.97
0.00
2.0
1.6
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
97
0.93
0.00
2.3
1.4
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.0
—
382.0
—
0
5
(3026470) Cobalt [Mass/volume] in Blood
8
85
0.94
0.00
1.9
2.1
ug/l
4.0
3.2
—
8
74
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
7
0.00
0.00
0.0
2.0
—
156.7
—
0
7
(40760410) HLA-B [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
70
1.00
0.00
1.4
1.2
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
160.4
—
0
8
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
330.6
—
0
5
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
59
1.02
0.00
5.3
6.6
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
39.1
—
0
6
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
21.3
—
0
6
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
70
1.00
0.00
1.4
1.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
80
1.00
0.00
1.4
1.5
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
7.5
—
0
6
(3003888) Timothy IgE Ab [Units/volume] in Serum
13
130
1.00
0.00
1.0
1.1
u/ml
6.6
6.2
—
6
68
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.1
—
—
—
0
0
(3001729) Color of Synovial fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
78
0.90
0.00
2.3
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
18
180
1.00
0.00
1.1
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
80
1.00
0.00
1.4
1.5
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.3
—
29.2
—
0
6
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
77
0.91
0.00
1.0
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
56
0.89
0.00
1.4
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint G6_NEUATR and mortality.

Females

Parameter HR [95% CI] p-value
G6_NEUATR 7.442 [6.44, 8.6] < 0.001
Birth year 0.994 [0.99, 1.0] 0.176

During the follow-up period (1.1.1998 — 31.12.2019), 2750 out of 4587 females with G6_NEUATR died.

Males

Parameter HR [95% CI] p-value
G6_NEUATR 5.431 [4.76, 6.19] < 0.001
Birth year 0.986 [0.98, 1.0] 0.006

During the follow-up period (1.1.1998 — 31.12.2019), 3012 out of 5076 males with G6_NEUATR died.

Mortality risk

Mortality risk for people of age

years, who have G6_NEUATR.

N-year risk Females Males
1 0.823% 0.863%
5 3.911% 5.649%
10 10.404% 14.121%
15 19.039% 26.114%
20 31.816% 40.692%

Relationships between endpoints

↥

Index endpoint: G6_NEUATR – Systemic atrophies primarily affecting the central nervous system

GWS hits: 14

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data